JPMorgan Chase & Co. Raises Cellebrite DI (NASDAQ:CLBT) Price Target to $14.00

Cellebrite DI (NASDAQ:CLBT – Free Report) had its price objective boosted by JPMorgan Chase & Co. from $12.00 to $14.00 in a research report report published on Friday, Benzinga reports. They currently have an overweight rating on the stock. A number of other equities research analysts also recently issued reports on the stock. Bank of […]

Related Keywords

United States ,America ,Craig Hallum ,Zurcher Kantonalbank Zurich Cantonalbank ,William Blair ,Central Asset Investments Management Holdings Hk Ltd ,Cellebrite Di Ltd ,Jpmorgan Chase Co ,Hennessy Advisors Inc ,Needham Company ,Free Report ,Lake Street Capital ,Get Free Report ,Asset Investments ,Management Holdings ,Kantonalbank Zurich Cantonalbank ,Hennessy Advisors ,Middle East ,